Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV ProphylaxisManjula Gunawardana, Marc M. Baum, Mariana Remedios-Chan et al.|Frontiers in Pharmacology|2020Cited by 23
Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized micePhilippe Gallay, Marc M. Baum, Udayan Chatterji et al.|PLoS ONE|2017Cited by 21
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxisManjula Gunawardana, Marc M. Baum, Mariana Remedios-Chan et al.|Scientific Reports|2022Cited by 19
Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance studyManjula Gunawardana, Marc M. Baum, Simon G. Webster et al.|Communications Medicine|2022Cited by 8
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure ProphylaxisManjula Gunawardana, Marc M. Baum, Mariana Remedios-Chan et al.|Pharmaceutical Research|2022Cited by 6